BASINGSTOKE, England (AFX) - Shire PLC said that in its pending New York litigation against Barr Laboratories Inc for the alleged infringement of patents, the court has scheduled the bench trial to start on Oct 30.
Barr is attempting to market a generic of Shire's Adderall XR hyperactivity treatment. newsdesk@afxnews.com cml/cml COPYRIGHT Copyright AFX News Limited 2005. All rights reserved. The copying, republication or redistribution of AFX News Content, including by framing or similar means, is expressly prohibited without the prior written consent of AFX News. AFX News and AFX Financial News Logo are registered trademarks of AFX News Limited
Barr is attempting to market a generic of Shire's Adderall XR hyperactivity treatment. newsdesk@afxnews.com cml/cml COPYRIGHT Copyright AFX News Limited 2005. All rights reserved. The copying, republication or redistribution of AFX News Content, including by framing or similar means, is expressly prohibited without the prior written consent of AFX News. AFX News and AFX Financial News Logo are registered trademarks of AFX News Limited